Citi Pharma Raises Rs. 2.32 Billion in the Single Largest Initial Public Offering (IPO) of 2021
According to Topline Securities, the issue’s advisor and book-runner, the book-building process for Citi Pharma’s Initial Public Offering (IPO) ended with a two-fold oversubscription. In a statement, the country’s top…
Share